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A Brugia malayi Homolog of Macrophage Migration Inhibitory
Factor Reveals an Important Link Between Macrophages and
Eosinophil Recruitment During Nematode Infection1
Franco H. Falcone,2,3 P’ng Loke,2,4 Xingxing Zang,4 Andrew S. MacDonald,5 Rick M. Maizels,
and Judith E. Allen6
Infections with the helminth parasite Brugia malayi share many key features with Th2-mediated allergic diseases, including
recruitment of eosinophils. We have investigated the dynamics of inflammatory cell recruitment under type 2 cytokine conditions
in mice infected with B. malayi. Among the cells recruited to the site of infection is a novel population of “alternatively activated”
macrophages that ablate cell proliferation and enhance Th2 differentiation. By profiling gene expression in this macrophage
population, we found a dramatic up-regulation of a recently described eosinophil chemotactic factor, eosinophil chemotactic
factor-L/Ym1, representing over 9% of clones randomly selected from a cDNA library. BecauseB. malayi is known to secrete
homologs (Bm macrophage migration inhibitory factor (MIF)-1 and -2) of the human cytokine MIF, we chose to investigate the
role this cytokine mimic may play in the development of the novel macrophage phenotype observed during infection. Strikingly,
administration of soluble recombinant Bm-MIF-1 was able to reproduce the effects of live parasites, leading both to the up-
regulation of Ym1 by macrophages and a marked recruitment of eosinophils in vivo. Because activity ofBm-MIF-1 is dependent
upon an amino-terminal proline, this residue was mutated to glycine; the resultant recombinant (Bm-MIF-1G) was unable to
induce Ym1 transcription in macrophages or to mediate the recruitment of eosinophils. These data suggest that macrophages may
provide a crucial link between helminth parasites, their active cytokine mimics, and the recruitment of eosinophils in
infection. The Journal of Immunology, 2001, 167: 5348–5354.
I nfection with helminth parasites is associated with elevated IgE,systemic eosinophilia, and mast cell proliferation (1). These fea-tures reflect a polarized type 2 T cell response enriched in IL-4,
IL-5, and IL-13 production (2, 3), and they are reminiscent of Th2-
mediated allergic airway inflammation (4). Helminth infection often
induces eosinophilic granulocytes to infiltrate host tissues in intense
foci associated with extensive tissue damage (5–7). Although many
components and regulatory features of the eosinophil recruitment
pathway have been elucidated (5, 7, 8), the molecular basis for the
massive infiltration of eosinophils during helminth infection is not
fully understood. Further, the role of eosinophils in immunity to hel-
minths remains the subject of considerable debate (9, 10).
Macrophages, activated by pro-inflammatory cytokines such as
IFN-, are critical in combating infection with intracellular micro-
organisms (11). In contrast, the type 2 cytokines IL-4 and IL-13
can activate macrophages toward a down-regulatory phenotype
(12–14). Such cells, termed alternatively activated macrophages
(AAM)7 may have immunoregulatory functions (12), but their
real purpose and range of activities in vivo is not known. One
possibility is that AAM dampen Th1- or Th2-mediated tissue-
damaging responses during infection with extracellular parasites
(15–17) and in allergic disease (18).
In a murine model of filarial infection, the human nematode
parasite Brugia malayi is surgically implanted into the peritoneal
cavity of mice (15, 16, 19, 20) where the recruitment of both
AAM and eosinophils occurs. In this paper we present evidence
for a link between the differentiation of AAM in response to this
nematode parasite and the recruitment of eosinophils to the site of
infection. Remarkably, we show that a cytokine homolog secreted
by the nematode parasite (Bm macrophage migration inhibitory
factor (MIF)-1) is involved in activating macrophages and is suf-
ficient for the recruitment of eosinophils.
Mammalian MIF was the first cytokine discovered (21) and is
involved in septic shock (22) and counteracting glucocorticoid ac-
tion (23). Interestingly, homologs of this cytokine have been iden-
tified in B. malayi (24) that share with human MIF a chemotactic
activity for monocyte/macrophages. An unusual feature of MIF
proteins is their enzymatic activity (25).8 In human MIF, mutation
of the conserved N-terminal proline to glycine substantially ablates
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both catalytic and cytokine activity (26). We now show that a B.
malayi homolog of MIF (Bm-MIF-1) induces eosinophil recruit-
ment in vivo when injected into the peritoneal cavity of mice and
that mutation of the conserved proline residue eliminates this ac-
tivity. We also find that Bm-MIF-1 increases the transcription rate
of a gene encoding a novel eosinophil chemotactic factor (ECF-L),
also known as Ym1 (27, 28). Gene expression analysis demon-
strates that Ym1/ECF-L represents over 9% of the total transcripts
in macrophages recruited to the site of B. malayi infection. Im-
portantly, Ym1 has been demonstrated to have chemotactic activ-
ity for eosinophils both in vitro and in vivo (28). These findings
demonstrate an important link between macrophage activation and
eosinophil chemotaxis and they suggest that Ym1 may be an im-
portant new player in helminth driven inflammatory processes.
Materials and Methods
Mouse strains
Six- to 8-wk-old CBA/Ca or C57BL/6 males were used for B. malayi
implantation. Both male and female BALB/c mice were used for the in-
jection of Bm-MIF-1 or LPS in vivo. C57BL/6 IL-4-deficient (IL-4/)
breeding pairs were purchased from B & K Universal (North Humberside,
U.K.) with permission of the Institute of Genetics (University of Cologne,
Cologne, Germany). C57BL/6 IL-5-deficient (IL-5/) mice (29) were the
kind gift of Dr. M. Kopf (Basel Institute for Immunology, Basel, Switzer-
land). All mice were bred in-house.
In vivo mouse models
B. malayi adult parasites were obtained from infected jirds purchased from
TRS Laboratories (Athens, GA). Adult worms were removed from the
peritoneal cavity of jirds, washed in RPMI, and six live adult B. malayi
females were surgically implanted into the peritoneal cavity of the mice.
After the experimental period, mice were euthanized by cardiac puncture,
and peritoneal exudate cells (PEC) were harvested by thorough washing of
the peritoneal cavity with 15 ml of RPMI. For analysis of Bm-MIF activity
in vivo, 1 g of purified, LPS-free recombinant Bm-MIF-1 and Bm-
MIF-1G were injected i.p. into mice three times a week for 3 wk (nine
injections) 3 days after the final injection the PEC cells were harvested as
described above.
Characterization of PEC populations
Cytocentrifuge preparations of 1  105 cells were made using a Shandon
Cytospin (Thermo Shandon, Pittsburgh, PA). Cytospins were air dried,
fixed in methanol, and stained with DiffQuik (Dade, Unterschleissheim,
Germany) and examined with a Nikon Microphot-FX microscope (Nikon,
Melville, NY). Before magnetic bead cell purification, PEC were passed
through a 70-m cell strainer and were purified by centrifugation over
Histopaque (Sigma-Aldrich, St. Louis, MO) to remove any microfilariae.
PEC were then sorted with MS or VS columns according to the man-
ufacturer’s instructions (Miltenyi Biotec, Auburn, CA). F4/80 cells were
purified with biotin-conjugated F4/80 (rat IgG2b; Caltag Laboratories, Bur-
lingame, CA) and streptavidin microbeads (Miltenyi Biotec).
cDNA library construction and express sequence tag analysis
Total RNA was extracted (with RNAstat60; Ambion, Austin, TX) from
purified F4/80 macrophages from the PEC of B. malayi-implanted IL-5-
deficient mice. cDNA was synthesized from total RNA and was unidirec-
tionally cloned into the pCMV-Script plasmid vector, using the cDNA
library construction kit from Stratagene (La Jolla, CA). Single clones from
the unamplified library were randomly picked, and the cDNA inserts were
amplified using vector primers T3 (AATTAACCCTCACTAAAGGG) and
T7 (CGGGATATCACTCAGCATAATG). Inserts were sequenced using
the 5 vector primer SAC (GGGAACAAAAGCTGGAG) and ABI Big
DYE terminators (PerkinElmer/Cetus, Norwalk, CT). Sequencing reac-
tions were analyzed using an ABI 377 automated sequencer (PerkinElmer/
Cetus, Norwalk, CT). The sequences were edited manually with vector
(SeqEd; Applied Biosystems, Foster City, CA) and poor 3 sequence re-
moved. The edited sequences were sent to the National Center for Bio-
technology Information for Blastn analysis against GenBank sequences
(nr) and the expressed sequence tag (EST) database (dbest). Blastx analysis
was also conducted against GenBank sequences (nr).
RT-PCR
For RT-PCR, first-strand cDNA was produced with oligo-dT primers from
total RNA using the GeneAmp RT-PCR kit (Applied Biosystems). Ym1-
specific primers (Ym1-For, TGG GGG ATC CG T ACC AGC TGA TGT
GCT ACT (64–82); Ym1-Rev, GTA AAG GAT CC T CAA TAA GGG
CCC TTG CA (1197–1182)) were used to amplify from the first-strand
cDNA. The Ym1 primers have an 18-bp overlap with the 5 and 3 end of
the target gene and an 11-bp overhang containing restriction sites designed
for a different purpose (overhanging nucleotides are in italics). As a con-
trol, we used primers for -actin (-actin-F, TGGAATCCTGTGGCATC
CATGAAAC and -actin-R, TAAAACGCAGCTCAGTAACAGTCCG).
PCR conditions were as follows: 94°C for 3 min, 35 cycles of 20 s at 94°C,
30 s 55°C, and 90 s at 72°C resulting in a 1506-bp amplicon for Ym1 and
348-bp for -actin. For real-time PCR (Light Cycler; Roche Diagnostic
Systems, Somerville, NJ), PCR on first-strand cDNA was performed using
the SYBR green kit (Roche Diagnostic Systems) with a second pair of
Ym1-specific primers (Ym1 -FLC, TCACAGGTCTGGCAATTCTTCTG;
Ym1 -RLC, TTTGTCCTTAGGAGGGCTTCCTCG), resulting in a 437-bp
product. The -actin primers shown above were also used for -actin
mRNA determination by real-time PCR.
Bm-MIF-1
Recombinant Bm-MIF-1 and Bm-MIF-1G were prepared as described else-
where.8 Briefly, native and mutant proteins were expressed in E. coli using
pET29 (Novagen, Madison, WI) with a C-terminal His-tag allowing puri-
fication to 97% homogeneity. Endotoxin was removed by phase separa-
tion using Triton X-114 (30) and was determined to be LPS free by a
commercial assay (E-Toxate; Sigma-Aldrich). Control experiments with
LPS were performed with LPS E. coli Serotype 026:B6 (Sigma-Aldrich).
Statistical analysis
Statistical analysis was performed using PRISM (GraphPad Software, San
Diego, CA). The nonparametric Mann-Whitney test was used to determine
measured differences between groups of mice (n  30), and the 2 test was
used to determine significant differences between the number of mice that
up-regulate Ym1 after treatment.
Results
Recruitment of macrophages and eosinophils by B. malayi
Implantation of B. malayi filarial parasites into the peritoneal cav-
ity of mice leads to dramatic recruitment of inflammatory cells,
with a 5- to 10-fold increase in total cell numbers by 3 wk postin-
fection (20). Within this population, the predominant cell types are
macrophages and eosinophils, the latter having increased by 40-
fold in the implanted mice. To determine the kinetics of recruit-
ment, we studied the development of peritoneal cell populations
over 21 days after exposure to B. malayi. After an initial drop in
the first 2 days, the total number of cells increased steadily, reach-
ing maximum levels at 2–3 wk (Fig. 1A). Mast cells disappeared
within 24 h of implantation by which time there was a striking but
short-lived neutrophilia (Fig. 1B). In contrast, eosinophil infiltra-
tion was observed slightly later, peaking at 7 days after implanta-
tion and remaining stable until the experiment was terminated at
21 days. As with total cell numbers, macrophage numbers steadily
increased in the first 2 wk (from 1.67  106  0.81  106 on day
0 to 5.12  106  0.86  106 on day 14) and then remained high
for the duration of the experiment (6.57  106  3.54 on day 21;
Fig. 1, A and B).
To assess whether the recruitment of eosinophils was dependent
on the Th2 cytokines IL-4 and IL-5, we implanted parasites into
IL-4- and IL-5- deficient mice (Fig. 1, C and D) for 3 wk before
recovering the PEC. Significantly fewer eosinophils were recruited
into the peritoneal cavity of IL-4/,whereas, as expected, eosin-
ophil recruitment was virtually absent in IL-5/ mice. These data
show that eosinophil recruitment in this model is dependent not
only on IL-5, but is also partly dependent on host IL-4.
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Characterization of gene expression in AAM
Peritoneal macrophages recruited by B. malayi profoundly sup-
press cellular proliferation through a contact-dependent mecha-
nism (16). This suppressive phenotype is entirely dependent on the
presence of host IL-4 (20). To explore the molecular basis of the
IL-4-dependent phenotype, we constructed a cDNA library from
purified F4/80 macrophages, for EST sequencing of randomly
selected clones. Macrophages were taken from parasite-implanted
IL-5/ mice, which possess identical suppressive function to im-
planted wild-type mice (16), as an additional precaution to exclude
any eosinophil contribution to the cDNA library.
A total of 252 clones were sequenced from the 5 end to provide
a snapshot of the abundant genes expressed by these suppressive
macrophages (Table I). Among the genes highly represented in the
library is arginase I, which counteracts the nitric oxide synthesis
pathway in macrophages and is induced by Th2 cytokines (31).
This finding supports our classification of B. malayi-recruited mac-
rophages as AAM. The abundant expression of a novel cysteine-
rich protein (PMNG1) by in vivo-derived AAM is of significant
interest and is the subject of ongoing investigation in the labora-
tory. However, the most striking finding was the extremely high
representation of a gene of unknown function submitted to the
database as Ym1 (27), which accounted for 9.1% of the cDNA
clones in this library. In a recent series of studies, Owhashi et al.
(32, 33) isolated an ECF produced by CD8 T lymphocytes
(ECF-L) after infection with Schistosoma japonicum and Toxocara
canis. This factor was biochemically purified and was shown by
direct protein sequencing to be Ym1 (28). These investigators then
isolated the cDNA clone and demonstrated that both native and
recombinant ECF-L/Ym1 was chemotactic for eosinophils in vitro
and in vivo (28).
Ym1 is dramatically up-regulated in macrophages exposed to
B. malayi
The discovery that a novel ECF accounted for a startlingly high
proportion of the genes expressed in peritoneal macrophages of
nematode-implanted mice was highly provocative. We confirmed
this finding by an independent RT-PCR analysis (Fig. 2). In resi-
dent PECs from control mice, Ym1 was routinely detected at a
low, basal level. In comparison, implantation of mice with para-
sites resulted in the dramatic up-regulation of Ym1 expression in
PECs after a period of 3 wk (Fig. 2A). This result was observed in
every individual mouse of either sex (n  10) analyzed by RT-
PCR. Using real-time PCR, we estimated that Ym1 is up-regulated
by 10,000-fold as a result of parasite implantation (Fig. 2B) and
is even more abundantly expressed than -actin, which is consis-
tent with our preliminary EST analysis.
Because eosinophil recruitment is partly or totally dependent on
Th2 cytokines IL-4 and IL-5, we assessed whether Ym1 expres-
sion was diminished in mice deficient for these products. Purified
F4/80 macrophages from parasite-implanted IL-5/ mice
FIGURE 1. Eosinophil recruitment by B. malayi. Time course of (A) total cell recruitment into the peritoneal cavity and (B) changes in the cellular
composition after parasite implantation. Cellular composition was determined separately for individual mice and data shown represents the mean for each
group. C, Eosinophil recruitment into the peritoneal cavity of implanted IL4/ mice; D, IL-5/ mice and WT mice. All data are shown as mean  SD
for individual mice (usually five per group) assessed separately.
Table I. Abundantly expressed transcripts in AAM	 recruited by B.
malayia
No. of Clones % Transcript GenBank Match (accession no.)
23 9.1 Ym1/ECF-L (BAA13458)
8 3.2 FIZZ1/PMNG1 (NP_065255)
6 2.4 Serum amyloid A 3 (NP_035445)
5 2.0 Arginase 1 (NP_031508)
a A cDNA library was constructed from AAM	 recruited by B. malayi. Randomly
selected clones (252) were sequenced from a cDNA library constructed from AAM	
recruited by B. malayi. Data is shown for the transcripts represented by more than 4
clones in this EST analysis.
5350 FILARIAL MIF ACTIVATES MACROPHAGES TO RECRUIT EOSINOPHILS
showed the same induction of Ym1 as wild-type mice (Fig. 2A).
This was expected as Ym1 was originally observed in a cDNA
library of IL-5/ origin. In the absence of IL-5, eosinophils fail
to mobilize from the bone marrow and therefore even with abun-
dant Ym1 produced, eosinophils would not be recruited (34). More
significantly, we found that F4/80 macrophages from IL-4/
mice also showed the same up-regulation of Ym1 (Fig. 2A) despite
reduced eosinophil recruitment. In IL-4 / mice, the failure to
make a full-fledged Th2 response may lead to reduced numbers of
IL-5-producing Th2 cells and thus reduced eosinophilia. This data
demonstrates that induction of Ym1 in this setting is independent
of IL-4 or IL-5, but it does not rule out a requirement for type 2
cytokines such as IL-13.
Bm-MIF-1 induces up-regulation of Ym1
B. malayi has been recently shown to secrete homologs of the
human cytokine MIF (24) that actively stimulate human mono-
cytes and macrophages. Therefore, we asked whether Bm-MIF-1
could be responsible for the Ym1 induction seen in macrophages
from implanted mice. To mimic the long-term effect of parasite
secretions, we gave nine i.p. injections of endotoxin-free Bm-
MIF-1 over a period of 3 wk. Both mammalian and parasite MIFs
display cytokine activity and an unusual enzyme specificity,
dopachrome tautomerase (25, 35, 36). Both activities are depen-
dent upon the N-terminal proline residue. Therefore, we tested a
mutant form of Bm-MIF-1, in which the proline has been altered to
glycine (Bm-MIF-1G) and lacks biological activity.8 We treated
two control groups with corresponding volumes of sterile PBS or
LPS (0.1 U/injection). Three days after the last injection, the an-
imals were sacrificed and the cells recruited to, or resident in, the
peritoneal cavity were processed for RT-PCR analysis.
As shown in Fig. 3A and Table II, Bm-MIF-1 induced Ym1 (11
of 16 mice), whereas in the PBS-treated mice, Ym1 was only de-
tected at a basal level. Interestingly, Bm-MIF-1G only induced
Ym1 in 2 of 16 mice. From this result, it appeared that the bio-
logical activity, dependent upon an intact N-terminal proline, was
responsible for the induction of Ym1. Also shown in Table II, LPS
was not effective at inducing Ym1 in treated mice. To ensure that
Ym1 was up-regulated in macrophages and that the increased tran-
script levels were not the result of increased macrophage numbers,
PECs were pooled from each group and the F4/80 cells were
purified with immunomagnetic beads for RT-PCR analysis. F4/
80 cells from Bm-MIF-1-injected mice expressed high levels of
Ym1 (Fig. 3A).
Next we sought to perform a reliable quantification of Ym1
induction by Bm-MIF-1 using real-time PCR. In an independent
experiment, mice were again given nine injections of 1 g of Bm-
MIF-1, BmMIF-1G, or PBS over 3 weeks. Equalizing for -actin
mRNA content in all the samples (Fig. 3B), we detected a signif-
icant increase in the level of Ym1 transcript in mice treated with
Bm-MIF-1 (mean 610.6  1088) vs Bm-MIF-1G-treated mice
(mean 4.498  2.871) or PBS-treated mice (mean 0.7753 
0.9562; Fig. 3C). Nearly identical results were obtained with F4/
80 cells purified from pooled PECs (data not shown). Interest-
ingly, MIF-1G-treated mice showed a slight but significant in-
crease in Ym1 transcription, consistent with the data showing that
2 of 16 MIF-1G-treated mice had up-regulated Ym1 (Table II).
This indicates that the 1G mutation does not completely remove all
functional activity. We have seen similar residual activity in
MIF-1G when analyzing cytokine activity.8
It is of interest to note that 100% of parasite-exposed mice in-
duced Ym1, whereas 30% of mice exposed to Bm-MIF-1 failed to
induce this molecule (Table II). The results obtained with i.p. in-
jection of BmMIF are likely to differ from the live parasite exper-
iments because the live implanted parasites release native Bm-MIF
continuously over the 3 weeks of the duration of the experiment.
The nine injections given to the mice over the same period may
only partially mimic the live implant situation. We thus examined
whether the 3-wk treatment course with Bm-MIF-1 is required for
effective induction of Ym1. We treated mice with a single 10-g
dose or three 1-g doses spread over 1 week. The single injection
of a high dose of Bm-MIF-1 had no effect, whereas the three con-
secutive injections did induce Ym1 (data not shown). Again, nei-
ther PBS nor Bm-MIF-1G induced Ym1. A single high dose of
LPS (10 U) also did not induce Ym1 (data not shown). This sug-
gests that Ym1 induction requires the continuous release of Bm-
MIF-1 as would be found during live infection, and may explain
the failure of some Bm-MIF-injected mice to induce Ym1 tran-
scription. In addition, other components secreted by the live par-
asites may reinforce the effects of Bm-MIF-1. Unsurprisingly, Bm-
MIF-1 alone does not reproduce all the effects of parasite
implantation (i.e., recruited macrophages are not suppressive), ar-
guing strongly that the parasite is producing other immune mod-
ulatory factors.
Bm-MIF-1 induces recruitment of eosinophils
Assuming that Ym1 gene transcription reflects protein levels, and
with the knowledge that Ym1 (ECF-L) can recruit eosinophils in
vitro as well as in vivo (28), we asked whether there was any
FIGURE 2. Expression of Ym1 in B. malayi recruited macrophages. A,
RT-PCR analysis of Ym1 induction in peritoneal cells derived from non-
implanted (WT con) mice, implantation with B. malayi (WT imp), and
F4/80-purified macrophages from implanted IL-4/ (IL-4/ imp) or
IL-5/ mice (IL-5/ imp). B, Real-time PCR analysis of Ym1 expres-
sion in recruited peritoneal cells. Fluorescence of -actin controls cross-
over into a linear expansion phase at 10.41 PCR cycles for WT imp and
11.38 cycles for WT con. Ym1 fluorescence enters the linear phase for WT
imp at 8.59 cycles and 24.88 cycles for WT con. Using a standard curve of
known quantities of template, we estimate that Ym1 expression is up-
regulated by 10,000-fold. Data shown is representative of several inde-
pendent experiments with individual mice (refer to Table II).
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relationship between recruitment of eosinophils to the peritoneal
cavity and the induction of Ym1 gene expression by Bm-MIF-1.
We thus examined stained cytospins of cells derived from the peri-
toneal cavity of mice treated with PBS, Bm-MIF-1, or Bm-MIF-
1G, and we assessed the percentage of eosinophil granulocytes.
Fig. 4 shows that the 3-wk treatment of mice with Bm-MIF-1 led
to an average increase of 
3-fold in the number of peritoneal
eosinophils compared with PBS- or Bm-MIF-1G-treated mice
( p  0.0001). It is noteworthy that although the 1-wk treatment
with Bm-MIF-1 effectively induced Ym1, these mice did not dis-
play any increased eosinophil recruitment (data not shown). With-
out understanding more about both MIF and Ym1 function (and
their receptors), it is difficult to directly assess the reasons for this.
It may be that early in the inflammatory process there is insufficient
expression of Ym1 receptors, or a lack of other key players (cells
or soluble mediators) that are essential to the recruitment process.
Discussion
In this study we established that there is an important link between
the action of nematode-derived MIF-1, the activation of macro-
phages to produce Ym1, and the recruitment of eosinophils. We
have yet to establish the exact sequence of events as well as the
role of other critical players such as IL-13 and eotaxin. Nonethe-
less, our data suggest that Ym1 may be an important and hitherto
unrecognized player in eosinophil-associated inflammatory
conditions.
Ym1 is highly homologous to a family of chitinases (37) found
in bacteria, plants, and mammals. These molecules may have
evolved as a first-line defense against chitin-bearing pathogens
such as fungi, but they may also play a role in anti-helminth im-
munity, as chitin-related carbohydrates are present in larval and
egg stages (38). Sequence comparison between Ym1 and active
chitinases suggests that Ym1 may no longer possess chitinase ac-
tivity due to the replacement of an acidic residue in the active site
(28, 37). However, even in the absence of chitinase activity, Ym1
may still have the ability to bind carbohydrate structures. Such a
carbohydrate-binding activity may be the key to eosinophil che-
motaxis, as it has been shown that ecalectin, a lectin with affinity
for -galactosides, is also selectively and potently chemotactic for
eosinophils (39). Because neither chitinases nor lectins are related
Table II. Summary of RT-PCR studies on Ym1 expression in individual
mice implanted with live B. malayi or treatment with BmMIF-1 or
BmMIF-1G, PBS, or LPSa
Ym1/ECF-L Ym1/ECF-L p Value
Wild-type implant 10 0 0.0001
Wild-type control 0 5




a Since Ym1 is expressed at a basal level in resident peritoneal cells, we defined
Ym1 as samples with 50% intensity of -actin controls.
FIGURE 3. Expression of Ym1 after treatment with BmMIF-1. A, RT-PCR analysis of -actin and Ym1 mRNA in peritoneal cells from mice treated
with BmMIF-1, BmMIF-1G, or PBS. The right panel shows the same analysis for F4/80 peritoneal macrophages of BmMIF-1-treated mice. Data shown
is representative of several independent experiments with individual mice (refer to Table II). B and C, Real-time PCR analysis of Ym1 expression in
peritoneal cells from BmMIF-1-, BmMIF-1G-, and PBS-treated mice. B, -actin controls showing equal amounts of template in all samples. C, Using a
standard curve of known quantities of template, Ym1 expression was compared between individual mice. Data shown as mean  SD of individual mice.
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to other known ECFs, it will be interesting to study the molecular
mechanism of chemoattraction in detail.
Ym1 has also been described in three other contexts, each as-
sociated with pathological conditions in the lung. Guo et al. (40)
found that crystals in the lungs of viable moth-eaten mice (mev/mev)
are composed of Ym1 protein. These crystals were found in the
cytoplasm of alveolar macrophages and are thought to be similar to
the Charcot-Leyden crystals in humans associated with eosinophil-
rich inflammation of the lungs. In a model system of vaccination
with the helminth parasite, Schistosoma mansoni, protein crystals
were found in the pulmonary macrophages of infected mice along
with significant numbers of eosinophils (41). By amino-terminal
sequencing, these protein crystals were recently identified as Ym1
(R. A. Wilson, unpublished observations). The potential role for
Ym1 in the pathology of pulmonary diseases is further highlighted
by a recent study of murine pulmonary Cryptococcus neoformans
infection that suggests that Ym1-containing protein crystals are
responsible for significant cellular damage (42). Interestingly, in
both schistosome vaccination and cryptococcal infection, signifi-
cant eosinophilia can occur in the absence of a dominant type 2
immune response. This is consistent with our finding that Ym1
up-regulation is IL-4 independent.
Taken together, the findings thus far suggest that Ym1 is an
abundant molecule associated with eosinophil recruitment, lung
pathology, and type 2 cytokine environments. Interestingly, two
human homologs of Ym1 with unknown function, chitotriosidase
and human cartilage gp39, are expressed in activated macrophages
(43). Chitotriosidase is highly induced in patients with Gaucher’s
disease (44), whereas both chitotriosidase and human cartilage
gp39 are expressed in macrophages from atherosclerotic lesions
(45). It is particularly interesting to note that human chitotriosidase
may be relevant to lymphatic filariasis. In a recent study in South
India (46), filarial-infected individuals were significantly more
likely than uninfected individuals to have the HH variant of the
CHIT1 gene—a genotype that leads to decreased activity and lev-
els of chitotriosidase, suggesting this molecule may be involved in
host protection. In the context of lung pathology, the most closely
related Ym1 homolog (68% identity) is a gene, TSA1902, which is
expressed specifically in the lung (47). Functions for these human
homologs remain unknown and thus our studies may provide in-
sight into the role of these highly expressed human genes.
The relationship of MIF to eosinophil recruitment is highly pro-
vocative. Mammalian MIF is strongly associated with type 1 pro-
inflammatory conditions (22), whereas the role of nematode MIF
in parasite infection remains to be elucidated. Mammalian MIF has
not been reported to have eosinophil recruitment activity (directly
or indirectly), although interestingly it is produced by human eo-
sinophils (48), raising the possibility of a positive feedback loop.
We are currently investigating whether this is a yet undiscovered
function for MIF, which we have identified by studying the para-
site homolog. Our data strongly suggest that macrophages provide
a crucial link between parasitic infections and eosinophil chemo-
taxis. Because the production of MIF-like enzymatic activity has
been demonstrated in a variety of nematode parasites (35), Ym1
induction by parasite-secreted MIF and subsequent eosinophil re-
cruitment to the tissues could be a widely spread mechanism ac-
counting at least partially for the well-known phenomenon of tis-
sue eosinophilia in parasitic infections. Although each of these
events has been demonstrated in isolation, we have not yet shown
a direct link between BmMIF, YM1 induction, and recruitment of
eosinophils. Future studies with neutralizing Abs will be required
to find out whether these are the critical cascade of events that
occur during infection. Further, to understand the sequence of
events more thoroughly, we will need a far clearer picture of both
MIF and Ym1 function. What is the receptor for Ym1? What fac-
tors, in addition to MIF, induce Ym1 expression? What levels of
Ym1 protein are required for eosinophil recruitment? Are Ym1
crystals purely a pathological outcome or are they part of the nor-
mal inflammatory processes?
This work raises the possibility that MIF and/or Ym1 are im-
portant components in Th2-mediated pathology in general and, as
such, could be relevant to chronic inflammatory conditions such as
asthma. Finally, as the role of eosinophils in parasite infection
remains unresolved, it is intriguing to consider the evolutionary
rationale behind the production of MIF by filarial parasites. In
secreting this cytokine mimic, the parasite may be directly respon-
sible for high-level eosinophil recruitment, suggesting that eosin-
ophils may, under some circumstances, function to benefit rather
than destroy the parasite.
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FIGURE 4. Eosinophil recruitment into the peritoneal cavity after Bm-
MIF-1 treatment. A, The cell composition of PEC (from i.p. injected mice)
was determined by counting 
500 cells from randomly selected fields per
DiffQuik-stained cytospin. Data presented is from several independent ex-
periments. Each data point represents an individual animal, with the hor-
izontal bar representing the mean of the group. B, Example of the cellular
composition of PEC after BmMIF-1 injection. Eosinophils are indicated
with arrows. The other cells are macrophages (large) and lymphocytes
(small).
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